GlassScriptPhysician profile
Brian A Janek
NPI 1871888628
$3,678.14
in general payments reported to CMS, 2019-2025
30 companies · $640 in 2025
The $640 reported for 2025 was more than what 76% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,205 · 2022: $843 · 2023: $436 · 2024: $555 · 2025: $640.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,631.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,630.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $532.26 | 2021-2024 | Farxiga, Brilinta |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $430.10 | 2021-2025 | Lifevest |
| Merck Sharp & Dohme LLC | $370.05 | 2021-2025 | Verquvo, Capvaxive |
| Abbott Laboratories | $291.00 | 2021-2025 | Cardiomems |
| Amgen INC. | $265.98 | 2022-2025 | Repatha, Repatha |
| Kowa Pharmaceuticals America, INC. | $206.18 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $205.53 | 2022-2025 | |
| Actelion Pharmaceuticals US, INC. | $187.96 | 2021-2025 | Opsynvi, Uptravi |
| Irhythm Technologies, INC. | $134.78 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Janssen Pharmaceuticals, INC | $120.57 | 2021-2023 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $114.86 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $114.84 | 2021-2025 | Camzyos, Eliquis |
| Boston Scientific Corporation | $84.01 | 2024-2025 | Watchman Flx |
| Pfizer INC. | $82.91 | 2021-2025 | |
| Novo Nordisk INC | $68.88 | 2023-2025 | Ozempic, Rybelsus |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $66.59 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $52.60 | 2021-2024 | Dupixent |
| Mylan Specialty L.P. | $50.27 | 2021 | |
| Atricure, INC. | $47.24 | 2022-2024 | |
| Esperion Therapeutics, INC. | $41.03 | 2021 | |
| Sanofi-Aventis U.S. LLC | $37.14 | 2021 | |
| Endologix LLC | $23.73 | 2025 | Endocross Device, Torus Stent Graft System |
| Kestra Medical Technology Services, INC. | $21.59 | 2023 | Assure Wcd |
| Cashflow Solutions, LLC | $20.96 | 2023 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
| Bayer Healthcare Pharmaceuticals INC. | $20.13 | 2022 | |
| Paratek Pharmaceuticals, INC. | $19.03 | 2025 | Nuzyra |
| Inspire Medical Systems, INC. | $18.36 | 2025 | Inspire |
| Corcept Therapeutics | $18.17 | 2025 | Korlym |
| Scpharmaceuticals INC. | $16.78 | 2024 | |
| Amarin Pharma, INC. | $14.61 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Janek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.